sw-2

SW-2 is an bioactive chemical.

SW209049 is a stearoyl-CoA 9-desaturase inhibitor. SW209049 exhivits potent activity against H2122 cell with IC50 of 0.13uM.

SR 271425, a novel cytotoxic DNA-interacting agent, has broad antitumor activity in preclinical models.

SW208108 is a tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD).

SW203668 is an irreversible inhibitor of stearoyl-CoA desaturase (IC50 = 54 nM). It is selectively cytotoxic to H2122, H460, HCC44, and HCC95 cell lines that express cytochrome P450 (CYP) isoform CYP4F11 over eight other cancer cell lines that lack CYP4F11 in vitro (IC50s = 22-116 and >10,000 nM, respectively) and ectopic expression of CYP4F11 in SW203668-insensitive H1155 cells results in sensitization to SW203668. In vivo, SW203668 reduces tumor growth rate without reducing sebocyte production in the H2122 wild-type and nonobese diabetic severe combined immunodeficiency (NOD-SCID) mouse xenograft models when administered at doses of 20 and 6 mg/kg, respectively.

SW2_110A is a cell-permeable, selective chromosome group 8 chromosome domain (CBX8 ChD) inhibitor with a Kd of 800 nM. In vitro, SW2_110A is 5-fold more selective for CBX8 ChD than all other CBX enantiomers.

SW2_110A acetate is a selective, cell-permeable chromobox inhibitor of homologue CBX8 (Kd = 800 nM) bound to CBX8 N-terminal color gamut (ChD). SW2_110A acetate has a high affinity for CBX8N, inhibits the association between CBX8 and cell chromatin, and inhibits the proliferation of ML-AF9-induced THP1 leukemia cells.

SW2_152F is a potent and selective inhibitor of the chromobox 2 chromodomain (CBX2 ChD), exhibiting a dissociation constant (K d) of 80 nM. It demonstrates 24-1000-fold greater selectivity for CBX2 ChD over other CBX paralogs in vitro [1].

P-gp/CDK2-IN-1 (Compound 4j) is an inhibitor of P-glycoprotein (P-gp) and cyclin-dependent kinase 2 (CDK2). It inhibits the proliferation of cancer cell lines SW-480 and MCF-7, with IC50 values of 38.6 μM and 26.6 μM, respectively. In the DPPH assay, P-gp/CDK2-IN-1 demonstrates antioxidant activity with an EC50 of 580 μM.

9β-Hydroxyhexahydrocannabinol is a synthetic cannabinoid derivative. It exhibits cytotoxicity against various tumor cell lines, including HCT-116, MCF-7, K562, MIAPaCa-2, PANC-1, A549, PC-3, and SW-620, with IC50 values ranging from 15.23 to 33.74 μM. This compound can be utilized in cancer research.

SAR502250 is a potent, selective, ATP-competitive, orally active, and brain-penetrant GSK3 inhibitor with a human GSK-3β IC50 value of 12 nM, exhibiting antidepressant-like activity and being researched for potential application in Alzheimer's disease (AD) treatment.

2-Hydroxymethyltetrahydropyran is a volatile compound identified in the seed oil of Sambucus williamsii (SW). Research indicates that SW seed oil possesses significant potential antioxidant activity. As one of its volatile constituents, this compound is utilized in studies focusing on component analysis, quality assessment, and the exploration of antioxidant properties in natural plant oils [1].

Divarasib (GDC-6036) adipate is a selective and highly potent KRAS G12C inhibitor with an impressively low IC 50 value of <0.01 μM, designed for oral administration. It covalently attaches to the switch II (SW-II) pocket in KRAS G12C, irreversibly maintaining the protein in its inactive GDP-bound state [1] [2].

4F-Docetaxel (4FDT) is a fluorinated derivative of docetaxel that exhibits significant antitumor activity against hepatocellular carcinoma (HCC) and is suitable for research on liver cancer.